Cargando…
The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice
BACKGROUND: Papillary thyroid cancer (PTC) is unique among cancers in that patient age is a consideration in staging. One of the most important modifications in the 8th Edition of the American Joint Committee on Cancer (AJCC) classification is to increase the age cut off for risk stratification in P...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708212/ https://www.ncbi.nlm.nih.gov/pubmed/33256657 http://dx.doi.org/10.1186/s12885-020-07636-0 |
_version_ | 1783617517946667008 |
---|---|
author | Kaliszewski, Krzysztof Diakowska, Dorota Nowak, Łukasz Wojtczak, Beata Rudnicki, Jerzy |
author_facet | Kaliszewski, Krzysztof Diakowska, Dorota Nowak, Łukasz Wojtczak, Beata Rudnicki, Jerzy |
author_sort | Kaliszewski, Krzysztof |
collection | PubMed |
description | BACKGROUND: Papillary thyroid cancer (PTC) is unique among cancers in that patient age is a consideration in staging. One of the most important modifications in the 8th Edition of the American Joint Committee on Cancer (AJCC) classification is to increase the age cut off for risk stratification in PTC from 45 to 55 years. However, whether this cut off is useful in clinical practice remains controversial. In the present study, we assessed how well this new age threshold stratifies patients with aggressive PTC. METHODS: We retrospectively analyzed the clinicopathological features and overall survival rate of patients with PTC admitted to and surgically treated at a single surgical center. The study protocol was divided into two series. In each series all patients (n = 523) were divided in 2 groups according to age cut off. In the first series (cut off 45) patients < 45 (n = 193) vs. ≥45 (n = 330) were compared, and in the second series (cut off 55) patients < 55 (n = 306) vs. ≥55 (n = 217) were compared. RESULTS: The rate of the prevalence of locally advanced disease (pT3 and pT4) was significantly higher in the patients above 55 years old than in those below 55 years old (p = 0.013). No significant differences were found for this parameter in series with cut off point 45 years old. A significantly higher risk of locally advanced disease T3 + T4 (OR = 4.87) and presence of LNM (N1) (OR = 3.78) was observed in ≥45 years old group (p = 0.021 and p < 0.0001, respectively). More expressive results were found for the patients ≥55 years old group, where the risk of locally advanced disease (T3 + T4) was higher (OR = 5.21) and LNM presence was OR = 4.76 (p < 0.001 and p < 0.0001, respectively). None of the patients below 55 years old showed distant metastasis, but 19 patients above 55 years old showed M1 (p < 0.0001). In older patients group (≥55 years old) we observed deaths related thyroid cancer in 11 individuals. CONCLUSIONS: The age cut off of 55 years old for risk stratification proposed by the 8th Edition of AJCC effectively stratifies PTC patients with a poor prognosis, indicating it is likely to be useful in clinical practice. |
format | Online Article Text |
id | pubmed-7708212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77082122020-12-02 The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice Kaliszewski, Krzysztof Diakowska, Dorota Nowak, Łukasz Wojtczak, Beata Rudnicki, Jerzy BMC Cancer Research Article BACKGROUND: Papillary thyroid cancer (PTC) is unique among cancers in that patient age is a consideration in staging. One of the most important modifications in the 8th Edition of the American Joint Committee on Cancer (AJCC) classification is to increase the age cut off for risk stratification in PTC from 45 to 55 years. However, whether this cut off is useful in clinical practice remains controversial. In the present study, we assessed how well this new age threshold stratifies patients with aggressive PTC. METHODS: We retrospectively analyzed the clinicopathological features and overall survival rate of patients with PTC admitted to and surgically treated at a single surgical center. The study protocol was divided into two series. In each series all patients (n = 523) were divided in 2 groups according to age cut off. In the first series (cut off 45) patients < 45 (n = 193) vs. ≥45 (n = 330) were compared, and in the second series (cut off 55) patients < 55 (n = 306) vs. ≥55 (n = 217) were compared. RESULTS: The rate of the prevalence of locally advanced disease (pT3 and pT4) was significantly higher in the patients above 55 years old than in those below 55 years old (p = 0.013). No significant differences were found for this parameter in series with cut off point 45 years old. A significantly higher risk of locally advanced disease T3 + T4 (OR = 4.87) and presence of LNM (N1) (OR = 3.78) was observed in ≥45 years old group (p = 0.021 and p < 0.0001, respectively). More expressive results were found for the patients ≥55 years old group, where the risk of locally advanced disease (T3 + T4) was higher (OR = 5.21) and LNM presence was OR = 4.76 (p < 0.001 and p < 0.0001, respectively). None of the patients below 55 years old showed distant metastasis, but 19 patients above 55 years old showed M1 (p < 0.0001). In older patients group (≥55 years old) we observed deaths related thyroid cancer in 11 individuals. CONCLUSIONS: The age cut off of 55 years old for risk stratification proposed by the 8th Edition of AJCC effectively stratifies PTC patients with a poor prognosis, indicating it is likely to be useful in clinical practice. BioMed Central 2020-11-30 /pmc/articles/PMC7708212/ /pubmed/33256657 http://dx.doi.org/10.1186/s12885-020-07636-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Kaliszewski, Krzysztof Diakowska, Dorota Nowak, Łukasz Wojtczak, Beata Rudnicki, Jerzy The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
title | The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
title_full | The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
title_fullStr | The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
title_full_unstemmed | The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
title_short | The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
title_sort | age threshold of the 8th edition ajcc classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708212/ https://www.ncbi.nlm.nih.gov/pubmed/33256657 http://dx.doi.org/10.1186/s12885-020-07636-0 |
work_keys_str_mv | AT kaliszewskikrzysztof theagethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT diakowskadorota theagethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT nowakłukasz theagethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT wojtczakbeata theagethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT rudnickijerzy theagethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT kaliszewskikrzysztof agethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT diakowskadorota agethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT nowakłukasz agethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT wojtczakbeata agethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice AT rudnickijerzy agethresholdofthe8theditionajccclassificationisusefulforindicatingpatientswithaggressivepapillarythyroidcancerinclinicalpractice |